Annual ROE
7.39%
-38.50%-83.90%
December 31, 2023
Summary
- As of February 7, 2025, AQST annual return on equity is 7.39%, with the most recent change of -38.50% (-83.90%) on December 31, 2023.
- During the last 3 years, AQST annual ROE has fallen by -107.63% (-93.58%).
- AQST annual ROE is now -93.58% below its all-time high of 115.02%, reached on December 31, 2020.
Performance
AQST ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
62.93%
+26.34%+71.99%
September 30, 2024
Summary
- As of February 7, 2025, AQST quarterly return on equity is 62.93%, with the most recent change of +26.34% (+71.99%) on September 30, 2024.
- Over the past year, AQST quarterly ROE has increased by +51.85% (+467.96%).
- AQST quarterly ROE is now -97.75% below its all-time high of 2794.46%, reached on March 31, 2019.
Performance
AQST Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AQST ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -83.9% | +468.0% |
| 3 y3 years | -93.6% | +468.0% |
| 5 y5 years | +101.2% | +468.0% |
AQST ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -91.4% | at low | -44.7% | +750.4% |
| 5 y | 5-year | -93.6% | +100.2% | -83.1% | +750.4% |
| alltime | all time | -93.6% | +100.2% | -97.8% | +100.7% |
Aquestive Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 62.93%(+72.0%) |
| Jun 2024 | - | 36.59%(+12.1%) |
| Mar 2024 | - | 32.65%(+341.2%) |
| Dec 2023 | 7.39%(-83.9%) | 7.40%(-33.2%) |
| Sep 2023 | - | 11.08%(-45.8%) |
| Jun 2023 | - | 20.45%(-33.3%) |
| Mar 2023 | - | 30.67%(-41.4%) |
| Dec 2022 | 45.89%(-46.6%) | 52.33%(-30.1%) |
| Sep 2022 | - | 74.85%(-14.9%) |
| Jun 2022 | - | 87.98%(-7.9%) |
| Mar 2022 | - | 95.49%(-16.1%) |
| Dec 2021 | 85.88% | 113.75%(-1.6%) |
| Sep 2021 | - | 115.60%(-13.9%) |
| Jun 2021 | - | 134.24%(-1.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | 136.34%(-22.3%) |
| Dec 2020 | 115.02%(-103.4%) | 175.37%(-22.6%) |
| Sep 2020 | - | 226.50%(-6.1%) |
| Jun 2020 | - | 241.13%(-23.8%) |
| Mar 2020 | - | 316.27%(-14.9%) |
| Dec 2019 | -3347.45%(+449.8%) | 371.68%(-24.2%) |
| Sep 2019 | - | 490.48%(-105.4%) |
| Jun 2019 | - | -9132.69%(-426.8%) |
| Mar 2019 | - | 2794.46%(+221.5%) |
| Dec 2018 | -608.89%(-1904.1%) | 869.23%(+145.1%) |
| Sep 2018 | - | 354.66%(+207.0%) |
| Jun 2018 | - | 115.51%(+740.7%) |
| Mar 2018 | - | 13.74%(-59.3%) |
| Dec 2017 | 33.75%(-38.2%) | 33.75% |
| Dec 2016 | 54.63% | - |
FAQ
- What is Aquestive Therapeutics annual return on equity?
- What is the all time high annual ROE for Aquestive Therapeutics?
- What is Aquestive Therapeutics annual ROE year-on-year change?
- What is Aquestive Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Aquestive Therapeutics?
- What is Aquestive Therapeutics quarterly ROE year-on-year change?
What is Aquestive Therapeutics annual return on equity?
The current annual ROE of AQST is 7.39%
What is the all time high annual ROE for Aquestive Therapeutics?
Aquestive Therapeutics all-time high annual return on equity is 115.02%
What is Aquestive Therapeutics annual ROE year-on-year change?
Over the past year, AQST annual return on equity has changed by -38.50% (-83.90%)
What is Aquestive Therapeutics quarterly return on equity?
The current quarterly ROE of AQST is 62.93%
What is the all time high quarterly ROE for Aquestive Therapeutics?
Aquestive Therapeutics all-time high quarterly return on equity is 2794.46%
What is Aquestive Therapeutics quarterly ROE year-on-year change?
Over the past year, AQST quarterly return on equity has changed by +51.85% (+467.96%)